Search EN menu en EIB GROUP CLIENT PORTAL
Close EIB GROUP CLIENT PORTAL
Search
Search
Results
Top 5 search results See all results Advanced search
Top searches
    Most visited pages

        ALK-ABELLO ALLERGY TREATMENT R&D

        Signature(s)

        Amount
        € 40,000,000
        Countries
        Sector(s)
        Denmark : € 40,000,000
        Industry : € 40,000,000
        Signature date(s)
        10/06/2010 : € 40,000,000

        Summary sheet

        Release date
        24 June 2009
        Status
        Reference
        Signed | 10/06/2010
        20080780
        Project name
        Promoter - financial intermediary
        ALK-Abello Allergy Treatment R&D
        ALK-Abello A/S
        Proposed EIB finance (Approximate amount)
        Total cost (Approximate amount)
        EUR 40 million.
        EUR 97.5 million.
        Location
        Sector(s)
        Description
        Objectives

        The project consists of Alk Abello's R&D activities, particularly those related to the development tablet based treatments for trees and ragweed pollen allergy, house dust mite and cat allergy and to the development of scientific models that lead to a better understanding of the immunological mechanisms of allergy and vaccination therapy, which can be used in next generation immuno-allergy vaccines. The project will be implemented in the period 2009-2010.

        The project should strengthen the market position of one of the EU-based market leaders, operating in the global market for allergen immunotherapy.

        Environmental aspects
        Procurement

        The project is expected to have no significant environmental impact.

        Procurement is in line with EIB guidelines for the private sector projects.

        Disclaimer

        Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
        They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

        General enquiries and comments

        The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
        Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
        Alternatively, the EIB can be contacted through its external offices.
        Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

        Media enquiries

        Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

        Complaints mechanism

        Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

        Zero tolerance against fraud and corruption

        The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

        Related publications